SCHEMBL29645831

SCHEMBL29645831

C[C@@H](N)C(=O)NCC(C)(C)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.39
FPR2 P25090 1/20 0.38
DPP4 P27487 2/20 0.38
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
SLC15A1 P46059 1/20 0.36
CNR1 P21554 5/20 0.34
CNR2 P34972 5/20 0.34
TERT O14746 2/20 0.34
TRPA1 O75762 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
CARM1 Q86X55 2/20 0.33
PRMT6 Q96LA8 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
PAX8 Q06710 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19882810 1.00 PIK3CD (0.39) PIK3CDFPR2DPP4PPARGPPARD
SCHEMBL14442120 0.84 DPP4 (0.39) DPP4SLC15A1TERTCARM1PRMT6
SCHEMBL13209257 0.84 DPP4 (0.39) DPP4SLC15A1TERTCARM1PRMT6
SCHEMBL28308562 0.83 DPP4 (0.38) DPP4SLC15A1TERTCARM1PRMT6
SCHEMBL22987679 0.83 DPP4 (0.38) DPP4SLC15A1TERTCARM1PRMT6
SCHEMBL10311712 0.82 PIK3CD (0.42) PIK3CDFPR2DPP4PPARGPPARD
SCHEMBL4126714 0.81 DPP4 (0.43) PIK3CDFPR2DPP4PPARGPPARD
SCHEMBL23341077 0.81 DPP4 (0.36) DPP4SLC15A1TERTCARM1PRMT6
SCHEMBL1582483 0.80 MEN1 (0.45) PIK3CDFPR2PPARGPPARDPPARA
SCHEMBL23173377 0.79 KDM4E (0.38) FPR2DPP4SLC15A1TERTCARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114466850-A [1,2,4] triazolo [1,5-C ] quinazolin-5-amines 拜耳股份有限公司 2022-05-10 CN claimed
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 PIK3CD 2082/4885FPR2 320/4885DPP4 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.